Impact on prostate cancer clinical presentation after non-screening policies at a tertiary-care medical center- a retrospective study
Abstract Background In May 2012 the US Preventive Task Force issued a ‘D’ recommendation against routine PSA-based early detection of prostate cancer. This recommendation was implemented progressively in our health system. The aim of this study is to define its impact on prostate cancer staging at a...
Main Authors: | Tarek Ajami, Jaime Durruty, Claudia Mercader, Leonardo Rodriguez, Maria J. Ribal, Antonio Alcaraz, Antoni Vilaseca |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-02-01
|
Series: | BMC Urology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12894-021-00784-w |
Similar Items
-
Controversies in Prostate Cancer Screening: is the Prostate Specific Antigen useful?
by: Pablo Yago Giménez, et al.
Published: (2019-12-01) -
Prostate cancer screening with prostate-specific antigen: A guide to the guidelines
by: Sonja Cabarkapa, et al.
Published: (2016-12-01) -
Beyond prostate-specific antigen: alternatives for prostate neoplasm screening
by: Yu, Kevin Kuo-Han
Published: (2016) -
The results of prostate cancer screening and the problem of the hyperdiagnosis of the disease in the Republic of Belarus
by: S. A. Krasnyi, et al.
Published: (2016-05-01) -
Prostate-specific antigen-based population screening for prostate cancer: current status in Japan and future perspective in Asia
by: Yasuhide Kitagawa, et al.
Published: (2015-06-01)